Program Co-Chairs
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee
Yehuda Handelsman, MD, FNLA, FACP, MACE
Medical Director & Principal Investigator
Metabolic Institute of America
Tarzana, California
PROGRAM OVERVIEW
This enduring activity will strengthen learners’ ability to apply guideline-based recommendations and cardio-renal metabolic (CMD) pathophysiology for the screening, diagnosis, and referral of patients with chronic kidney disease (CKD) and/or heart failure (HF). It will also highlight the use of current evidence to develop comprehensive, cardiorenal-focused treatment plans and emphasize shared decision-making (SDM) and multidisciplinary collaboration (MDT) to optimize patient care.
TARGET AUDIENCE
This educational activity is designed to meet the needs of healthcare providers in primary care, including general/family physicians and/or internal medicine physicians (PCPs), primary care advanced practice providers (APPs; e.g., nurse practitioners and physician’s assistants), and endocrinologists who play a crucial role in diagnosing and treating patients with chronic kidney disease (CKD) and heart failure (HF) as a result of cardio-renal metabolic disease (CMD). This activity is also designed to provide education on the optimal care of CKD and HF through the multidisciplinary team (MDT), as well as evidence-based treatment approaches.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply guideline recommendations and CMD pathophysiology to aid in the screening, diagnosis, and specialty referral for patients with CKD and/or HF.
- Employ the latest clinical evidence and guideline recommendations to create comprehensive treatment plans that provide cardiorenal benefits for patients with CKD and/or HF.
- Practice SDM to incorporate the patient’s perspective in therapy decisions and collaborate with the patient’s MDT to create a comprehensive therapy plan when treating patients with CKD and/or HF.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.50 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid until June 25, 2027. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Relationships | Manufacturer |
| John E. Anderson, MD | Consultant | Abbott Diabetes, AstraZenca, Boehringer Ingelheim, Corcept Therapeutics, Eli Lilly, Insulet, and Sanofi |
| Speaker Bureau | Abbott, Corcept Therapeutics, Eli Lilly and Sanofi | |
| Yehuda Handelsman, MD, FNLA, FACP, MACE | Consultant | Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Regeneron, Sanofi, Verdiva Bio |
| Speaker Bureau | Boehringer Ingelheim, Novo Nordisk | |
| Fee for Non-CME Services | Arrowhead | |
| Contracted Research | AstraZeneca, Corcept, Ionis, Merck & Co., Regeneron, Verdiva Bio |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Dominique Barton, BS, BSN, has nothing to disclose.
- A medical reviewer from CE Peer Review LLC, has nothing to disclose.
- Surabhi Dangi-Garimella, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation & Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Felecia Beachum, Sr. Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: June 25, 2026
EXPIRATION DATE: June 25, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
